PARP inhibitors for metastatic castration-resistant prostate cancer: Biological rationale and current evidence

Autor: Bieńkowski, Michał, Tomasik, Bartłomiej, Braun, Marcin, Jassem, Jacek
Zdroj: In Cancer Treatment Reviews March 2022 104
Databáze: ScienceDirect